Extracellular vesicle therapeutics for cardiac regeneration: Overcoming standardization hurdles

Table 1 Comparative analysis of major extracellular vesicles isolation methods for clinical translation

Method	Recovery yield	Purity	Throughput/processable volume	Time/cost	Impact on bioactivity	Preservation of subpopulations
UC	Low (+)	Moderate (co-isolates protein aggregates & non-exosomal vesicles)	Low/difficult to scale (+)	Time: High; cost: Low (-)	Potential vesicle damage & aggregation due to high g-forces (-)	Poor (differential sedimentation may bias populations) (-)
SEC	Moderate (++)	High (effective removal of soluble proteins & contaminants) (++)	Moderate/challenging for large volumes (++)	Time: Moderate; cost: Moderate (++)	Gentle, maintains structural integrity & function (++)	Good (separation by hydrodynamic size, can preserve heterogeneity) (++)
TFF	High (+++)	Moderate (can require combination with SEC for high purity) (++)	High/highly scalable (handles large volumes) (+++)	Time: Low; cost: Moderate (+++)	Gentle, suitable for labile biologics (+++)	Good (size-based, less shear damage than UC) (++)
AEC	High (+++)	High (binds negatively charged vesicles, effective impurity removal) (+++)	High/scalable (+++)	Time: Low; cost: Moderate (+++)	Depends on elution conditions (salt/pH may affect activity) (+)	Moderate (may select for specific surface charge populations) (+)
Microfluidic technology	Variable (device-dependent) (+) to (++)	High (precise manipulation & sorting) (+++)	Low/currently limited by chip design (+)	Time: Rapid processing; cost: High per-device (research stage) (+)	Generally gentle (+++)	Promising for specific subpopulation isolation (precise sorting) (+++)

+++: Excellent/high; ++: Good/moderate; +: Fair/Low; -: Poor/negative impact. This semi-quantitative assessment integrates data from referenced studies and current field consensus. The optimal method choice often involves combining techniques (e.g., tangential flow filtration + size exclusion chromatography) to balance yield, purity, and bioactivity. UC: Ultracentrifugation; SEC: Size exclusion chromatography; TFF: Tangential flow filtration; AEC: Anion exchange chromatography.

Table 2 Testing technologies for critical quality attributes of extracellular vesicles

Attribute category	Critical quality attributes	Example testing technologies
Physical characterization	Particle size distribution & concentration	NTA
	Single-particle sizing & surface markers (e.g., CD9, CD63, CD81)	Nanoscale flow cytometry
	Morphology/structure	TEM
	Mechanical properties (e.g., stiffness, viscoelasticity)	AFM
Molecular profiling	Protein composition (including marker & functional proteins)	Proteomics
	miRNA composition & profile	miRNA sequencing
	Lipid composition	Lipidomics
Functional potency	Cell survival/anti-apoptotic capacity	Functional cell-based assays (e.g., caspase-3 activity)
	Calcium handling capacity	Functional cell-based assays (e.g., calcium imaging)
	Mitochondrial function	Functional cell-based assays (e.g., mitochondrial membrane potential measurement)

NTA: Nanoparticle tracking analysis; TEM: Transmission electron microscopy; AFM: Atomic force microscopy; miRNA: MicroRNA.